Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond

被引:93
|
作者
Mullican, Shannon E. [1 ]
Rangwala, Shamina M. [1 ]
机构
[1] Janssen Pharmaceut Inc, Cardiovasc & Metab Therapeut Area, Spring House, PA 19477 USA
来源
关键词
TGF-BETA SUPERFAMILY; MACROPHAGE INHIBITORY CYTOKINE-1; DIFFERENTIATION FACTOR 15; ACTIVATED GENE NAG-1/GDF15; GROWTH/DIFFERENTIATION FACTOR-15; INTEGRIN ACTIVATION; UP-REGULATION; WEIGHT-LOSS; INSULIN-RESISTANCE; MOUSE MODEL;
D O I
10.1016/j.tem.2018.05.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Growth differentiation factor-15 (GDF15) is a circulating protein that has been implicated in multiple biological processes, including energy homeostasis, body weight regulation, and cachexia driven by cancer and chronic disease. The potential to target GDF15 in the treatment of energy-intake disorders, including obesity and anorexia, is an area of intense investigation, but has been limited by the lack of an identified receptor, signaling mechanism, and target tissue. GDNF family receptor alpha-like (GFRAL) was recently identified as the neuronal brainstem receptor responsible for mediating the anorectic actions of GDF15. Herein, we provide a brief overview of GDF15 biology with a focus on energy homeostasis, and highlight the implications of the recent receptor identification to this field and beyond.
引用
收藏
页码:560 / 570
页数:11
相关论文
共 50 条
  • [21] GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS
    Tsai, Vicky Wang-Wei
    Zhang, Hong Ping
    Manandhar, Rakesh
    Schofield, Peter
    Christ, Daniel
    Lee-Ng, Ka Ki Michelle
    Lebhar, Helene
    Marquis, Christopher Peter
    Husaini, Yasmin
    Brown, David A.
    Breit, Samuel N.
    INTERNATIONAL JOURNAL OF OBESITY, 2019, 43 (12) : 2370 - 2380
  • [22] GDF15: a potential therapeutic target for type 1 diabetes
    Sarkar, Soumyadeep
    Melchior, John T.
    Henry, Hayden R.
    Syed, Farooq
    Mirmira, Raghavendra G.
    Nakayasu, Ernesto S.
    Metz, Thomas O.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (01) : 57 - 67
  • [23] Expression of the Body-Weight Signaling Players: GDF15, GFRAL and RET and their clinical relevance in Gastric Cancer
    Buchholz, Karolina
    Antosik, Paulina
    Grzanka, Dariusz
    Gagat, Maciej
    Smolinska, Marta
    Grzanka, Alina
    Gzil, Arkadiusz
    Kasperska, Anna
    Klimaszewska-Wisniewska, Anna
    JOURNAL OF CANCER, 2021, 12 (15): : 4698 - 4709
  • [24] GDF15及其受体GFRAL在肥胖治疗上的相关研究进展
    刘凌志
    林春瑜
    汪建华
    张惟材
    游松
    熊向华
    生物技术通讯, 2018, 29 (05) : 708 - 711
  • [25] Advances in GDF15 research
    Morris, Alan
    NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (03) : 129 - 129
  • [26] Advances in GDF15 research
    Alan Morris
    Nature Reviews Endocrinology, 2020, 16 : 129 - 129
  • [27] Berberine Ameliorates Obesity by Inducing GDF15 Secretion by Brown Adipocytes
    Li, Chang
    Leng, Qingyang
    Li, Lihua
    Hu, Fan
    Xu, Yuejie
    Gong, Sa
    Yang, Ying
    Zhang, Hongli
    Li, Xiaohua
    ENDOCRINOLOGY, 2023, 164 (04)
  • [28] GDF15 and Growth Control
    Emmerson, Paul J.
    Duffin, Kevin L.
    Chintharlapalli, Sudhakar
    Wu, Xinle
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [29] GDF15 as a biomarker of ageing
    Liu, Huan
    Huang, Yun
    Lyu, Yongnan
    Dai, Wen
    Tong, Yongqing
    Li, Yan
    EXPERIMENTAL GERONTOLOGY, 2021, 146
  • [30] Camptothecin effectively treats obesity in mice through GDF15 induction
    Lu, Jun Feng
    Zhu, Meng Qing
    Xie, Bao Cai
    Shi, Xiao Chen
    Liu, Huan
    Zhang, Rui Xin
    Xia, Bo
    Wu, Jiang Wei
    PLOS BIOLOGY, 2022, 20 (02)